Greg graduated from Cornell University and joined the group in September 2017, as a research scientist. Greg will be working on the synthesis of novel molecules as potential treatments for a number of neurodegenerative diseases. In the future, Greg plans to pursue a career in medicine.
Mike is a chemistry graduate from Northeastern University and joined the group in April 2018, as a research scientist. Mike is working on the synthesis of novel molecules for a the EAAT2 project. In the future, Mike plans to pursue a career in medicine.
Dr. Kevin Hodgetts
Director of The Laboratory for Drug Discovery in Neurodegeneration
65 Landsdowne Street
Cambridge, Massachusetts 02139